F18.221
Inhalant dependence with intoxication delirium
Clinical Classification Guidelines
Medical Intelligence & Overview
Inhalant dependence with intoxication delirium is a medical condition characterized by an ongoing reliance on inhalants—substances that are breathed in to produce a high—and the presence of delirium during intoxication. This condition highlights the serious risks associated with inhalant abuse, including mental state disturbances and potential long-term health impacts. Recognizing this condition is vital for seeking appropriate medical attention and understanding the challenges involved in treatment.
Causes & Symptoms
Clinical Causes: Repeated use of inhalant substances like solvents, aerosols, glues, or nitrites Psychological factors such as peer pressure, stress, or mental health disorders Accessibility and low cost of inhalant substances making them appealing, especially among youth Lack of awareness about the dangers and health consequences of inhalant abuse History of substance abuse or mental health issues that predispose individuals to dependency
Key Symptoms: Altered mental state characterized by confusion, disorientation, or hallucinations Development of delirium with rapid shifts in consciousness Physical symptoms like dizziness, headache, and slurred speech Possible visual disturbances and impaired coordination Signs of inhalant dependence such as cravings and compulsive use Altered mood and possible aggressive or agitated behavior
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical assessment, including a detailed history of substance use and mental status evaluation. Healthcare providers may perform blood tests or toxicology screening to detect inhalant substances. Observing symptoms of delirium and understanding the pattern of inhalant use are essential components for confirming this diagnosis. Mental health evaluations are also conducted to assess underlying issues contributing to inhalant dependence.
Treatment Protocols: Hospital or clinical observation to manage acute intoxication and delirium Psychological counseling or psychotherapy to address dependency and underlying mental health issues Behavioral interventions such as cognitive-behavioral therapy (CBT) Support groups and community resources for ongoing assistance Education about the risks of inhalant use and relapse prevention plans
Clinical Advice & FAQs
Billing Guidance
Is F18.221 a billable ICD-10 code?
Yes, F18.221 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.221?
Clinical documentation must specify the nature of Inhalant dependence with intoxication delirium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference